{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:57:44Z","timestamp":1784249864915,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1093\/infdis\/jis940","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T13:14:21Z","timestamp":1357823661000},"page":"1066-1074","source":"Crossref","is-referenced-by-count":24,"title":["Proangiogenic Growth Factors Potentiate In Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis"],"prefix":"10.1093","volume":"207","author":[{"given":"Ronen","family":"Ben-Ami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,9]]},"reference":[{"key":"key\n\t\t\t\t20170702154626_JIS940C1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702154626_JIS940C2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702154626_JIS940C3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702154626_JIS940C4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2141.2010.08283.x","article-title":"Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection","volume":"150","author":"Ben-Ami","year":"2010","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C5","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-07-231209","article-title":"Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites","volume":"114","author":"Ben-Ami","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170702154626_JIS940C6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/dkg434","article-title":"Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B","volume":"52","author":"Paterson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170702154626_JIS940C7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bmj.1.4816.918","article-title":"Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy","volume":"1","author":"Rankin","year":"1953","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20170702154626_JIS940C8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis","volume":"73","author":"Balloy","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170702154626_JIS940C9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1309\/UJRV9DLC11RM3G8R","article-title":"Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis","volume":"127","author":"Stergiopoulou","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C10","doi-asserted-by":"crossref","first-page":"e1002145","DOI":"10.1371\/journal.ppat.1002145","article-title":"In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis","volume":"7","author":"Grahl","year":"2011","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702154626_JIS940C11","doi-asserted-by":"crossref","first-page":"e1000200","DOI":"10.1371\/journal.ppat.1000200","article-title":"A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus","volume":"4","author":"Willger","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702154626_JIS940C12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/978-1-61779-539-8_42","article-title":"A nonlethal murine cutaneous model of invasive aspergillosis","volume":"845","author":"Ben-Ami","year":"2012","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C13","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"key\n\t\t\t\t20170702154626_JIS940C14","doi-asserted-by":"crossref","first-page":"19866","DOI":"10.1073\/pnas.0606956103","article-title":"Phosphoinositide 3-kinase gamma\/delta inhibition limits infarct size after myocardial ischemia\/reperfusion injury","volume":"103","author":"Doukas","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702154626_JIS940C15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"Paris","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170702154626_JIS940C16","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/AAC.45.12.3474-3481.2001","article-title":"Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate","volume":"45","author":"Bowman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170702154626_JIS940C17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1086\/424465","article-title":"Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity","volume":"190","author":"Wiederhold","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702154626_JIS940C18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702154626_JIS940C19","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170702154626_JIS940C20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America","volume":"42","author":"Talbot","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702154626_JIS940C21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5858\/2008-132-606-TPOPDD","article-title":"The pathology of pulmonary disorders due to Aspergillus spp","volume":"132","author":"Kradin","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20170702154626_JIS940C22","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","article-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism","volume":"278","author":"Sau","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170702154626_JIS940C23","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.46.6.1974-1976.2002","article-title":"Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus","volume":"46","author":"Roilides","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170702154626_JIS940C24","first-page":"97","article-title":"Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis","volume":"237","author":"Dvorak","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/labinvest.3700436","article-title":"Permeability properties of tumor surrogate blood vessels induced by VEGF-A","volume":"86","author":"Nagy","year":"2006","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t20170702154626_JIS940C26","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2003-06-2186","article-title":"Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity","volume":"103","author":"Lopes Bezerra","year":"2004","journal-title":"Blood"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170702154626_JIS940C27","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/13693780600897989","article-title":"Interactions of Aspergillus fumigatus with vascular endothelial cells","volume":"44","author":"Kamai","year":"2006","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/152308602760598963","article-title":"Redox signaling of angiogenesis","volume":"4","author":"Maulik","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"key\n\t\t\t\t20170702154626_JIS940C30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/AEM.34.6.765-772.1977","article-title":"Occurrence of Aspergillus fumigatus during composting of sewage sludge","volume":"34","author":"Millner","year":"1977","journal-title":"Appl Environ Microbiol"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170702154626_JIS940C31","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1080\/13693780600779419","article-title":"Aspergillus fumigatus: growth and virulence","volume":"44","author":"Rhodes","year":"2006","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.mib.2008.09.018","article-title":"Fungal adaptation to the mammalian host: it is a new world, after all","volume":"11","author":"Cooney","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"key\n\t\t\t\t20170702154626_JIS940C33","doi-asserted-by":"crossref","first-page":"128608","DOI":"10.1155\/2012\/128608","article-title":"Angiogenesis in acute myeloid leukemia and opportunities for novel therapies","volume":"2012","author":"Trujillo","year":"2012","journal-title":"J Oncol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/207\/7\/1066\/18068418\/jis940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T11:22:47Z","timestamp":1714821767000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jis940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,1,9]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jis940","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717982885.793472072","asserted-by":"object"}]},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}